Claritev Corporation (CTEV)
NYSE: CTEV · Real-Time Price · USD
42.03
-0.66 (-1.55%)
At close: Dec 26, 2025, 4:00 PM EST
42.00
-0.03 (-0.07%)
After-hours: Dec 26, 2025, 7:00 PM EST
Claritev Market Cap
Claritev has a market cap or net worth of $694.57 million as of December 26, 2025. Its market cap has increased by 492.43% in one year.
Market Cap
694.57M
Enterprise Value
5.31B
1-Year Change
492.43%
Ranking
Category
Stock Price
$42.03
Market Cap Chart
Since April 3, 2020, Claritev's market cap has increased from $243.00M to $694.57M, an increase of 185.83%. That is a compound annual growth rate of 20.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 26, 2025 | 694.57M | 190.60% |
| Dec 31, 2024 | 239.01M | -74.44% |
| Dec 29, 2023 | 935.26M | 27.25% |
| Dec 30, 2022 | 734.99M | -74.01% |
| Dec 31, 2021 | 2.83B | -46.98% |
| Dec 31, 2020 | 5.33B | 2,094.66% |
| Apr 3, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 964.31B |
| Johnson & Johnson | 500.60B |
| AbbVie | 406.30B |
| UnitedHealth Group | 296.73B |
| AstraZeneca | 286.29B |
| Novartis AG | 267.64B |
| Merck & Co. | 264.21B |
| Novo Nordisk | 232.28B |